Saxena AR, Gorman DN, Esquejo RM et al (2021) Danuglipron (PF-06882961) in type 2 diabetes: a randomized placebo-controlled multiple ascending-dose phase 1 trial
Author Contributions Concept and design: Ibaadat Kahlon, Simone Sekhon , William Latson Acquisition, analysis, or interpretation of data: Ibaadat Kahlon, William Latson Drafting of the manuscript: Ibaadat Kahlon, Simone Sekhon , William Latson Critical review of the manuscript for important intellectual content: Ibaadat Kahlon, Simone Sekhon , William Latson Supervision: William Latson References 1.A new drug for obesity: tirzepatide
J Clin Endocrinol Metab 86 : 47534758 Cuntz U et al
By choosing different production options, a distiller can produce different Tequila for various companies from the same distillery